EC Number   |
Inhibitors |
Structure  |
|---|
    2.6.1.5 | beta-Methyl-L-aspartate |
with L-tyrosine and 2-oxoglutarate or oxaloacetate as substrates |
   |
| 2.6.1.5 | dihydroxymandelic acid |
65% inhibition with tyrosine at 3 mM and dihydroxymandelic acid at 3 mM |
|
| 2.6.1.5 | alpha-Methyl-L-aspartate |
with L-tyrosine and 2-oxoglutarate or oxaloacetate as substrates |
|
| 2.6.1.5 | kynuric acid |
10 mM, complete inhibition |
|
| 2.6.1.5 | 4-methylsulfonyl-2,5,6,2',4'-pentachlorobiphenyl |
significant reduction of dexamethasone-induced activity, 50% inhibition at 0.0007 mM |
|
| 2.6.1.5 | 4-methylsulfonyl-2,5,6,2',4',5'-hexachlorobiphenyl |
significant reduction of dexamethasone-induced activity, 50% inhibition at 0.0008 mM |
|
| 2.6.1.5 | tolylfluanid |
significant reduction of dexamethasone-induced activity, 50% inhibition at 0.0014 mM |
|
| 2.6.1.5 | cinmethylin |
0.5 mM: 96% inhibition of enzyme activity, 0.25 mM: 20% inhibition of enzyme activity |
|
| 2.6.1.5 | methiozolin |
0.5 mM: 91% inhibition of enzyme activity, 0.25 mM: 57% inhibition of enzyme activity |
|
| 2.6.1.5 | 3-(5-{[(2,6-difluorobenzyl)oxy]methyl}-5-methyl-4,5-dihydro-1,2-oxazol-3-yl)pyridine-2-carbonitrile |
1 mM: 82% inhibition of enzyme activity, 0.5 mM: 46% inhibition of enzyme activity, 0.25 mM: 8% inhibition of enzyme activity |
|
